Latest 20-F annual reports

WORK Medical Technology Group LTD's 20-F filing highlights risks associated with PRC regulations, competition, and potential delisting under the Holding Foreign Companies Accountable Act.

Golden Sun Health Technology Group's subsidiary, Xianjin Technology and Qinshang Education, provides a guarantee for Director Liming Xu's $1.85 million loan while the company files its annual report highlighting expansion into wellness and cultural tourism.

British American Tobacco's 2024 performance reflects resilience amid global economic challenges, with a strategic emphasis on transitioning to smokeless products.

Starbox Group Holdings Ltd. experienced a substantial net loss of $113.18 million in fiscal year 2024, despite generating $6.17 million in revenue, primarily due to increased operating expenses and decreased revenue from key business segments.

Prestige Wealth Inc.'s 20-F filing reveals a year of strategic shifts, including executive leadership changes, acquisitions aimed at technological advancement, and a focus on navigating the complexities of the wealth management and asset management sectors.

Barclays PLC's 2024 Annual Report on Form 20-F provides a comprehensive overview of the company's financial performance, risk management strategies, and progress towards its strategic goals, including sustainability and capital allocation.

Sanofi's 2024 20-F filing reveals a year of strategic transformation, marked by strong performance in key areas, significant R&D investments, and ongoing management of legal and regulatory risks.

Barclays Bank PLC releases its annual report on Form 20-F, detailing its financial performance and key strategic initiatives for the fiscal year ending December 31, 2024.

TELUS International (Cda) Inc. reports its financial results and operational activities for the fiscal year ended December 31, 2024, in its annual report on Form 20-F.

Ascendis Pharma's 20-F filing summarizes the company's financial performance, key developments, and future outlook, emphasizing its focus on endocrinology, rare diseases, and oncology.

Globavend Holdings Limited reports a decrease in revenue but an increase in net income for fiscal year 2024, while addressing ongoing risks and uncertainties.

Genmab A/S files its 20-F report, detailing its financial performance for the year ended December 31, 2024, and outlining key strategic initiatives and pipeline advancements.

Origin Agritech Limited files its 20-F, detailing financial results for the year ended September 30, 2024, and addressing ongoing regulatory and operational challenges in China.

BGM Group Ltd files an amendment to its annual report on Form 20-F to update information regarding principal accountant fees and services.

Spotify's 2024 annual report highlights the company's growth in users and subscribers, alongside its efforts to achieve sustained profitability and navigate the complexities of the audio streaming market.

Novo Nordisk A/S reports strong 2024 results driven by its Diabetes and Obesity care segment, while also outlining its commitment to sustainability and innovation.

InMode Ltd. expands its operational footprint with new lease agreements while facing revenue decline and legal challenges in 2024.

Nvni Group Limited reports a net loss for 2023 and identifies material weaknesses in internal controls, despite a 36% increase in net operating revenue.

EpicQuest Education Group International Limited reports increased revenue but significant net losses and going concern uncertainty in its annual report for the fiscal year ended September 30, 2024.

Tian Ruixiang Holdings Ltd files its annual report on Form 20-F, detailing its financial performance and operational structure for the fiscal year ended October 31, 2024.

Novartis AG released its 20-F filing, outlining its financial results for the year ended December 31, 2024, and providing insights into its strategic direction and operational activities.

Youxin Technology Ltd announced its fiscal year 2024 results, highlighting a strategic shift towards its PaaS platform and improved gross margins despite a revenue decline.

Huadi International Group's fiscal year 2024 saw a revenue decrease due to economic conditions and pricing adjustments, alongside ongoing efforts to manage costs and expand market reach.

Zapp Electric Vehicles Group Limited's 20-F filing reveals ongoing losses and liquidity challenges, alongside progress in vehicle homologation and micro-factory development.

Gamehaus Holdings Inc. finalizes a lock-up agreement and completes its business combination with Golden Star Acquisition Corporation.

Creative Global Technology Holdings Limited has released its annual report on Form 20-F for the fiscal year ended September 30, 2024, detailing its financial performance and business operations.

New Century Logistics (BVI) Limited announces its fiscal year 2024 results, highlighting a 44.64% increase in revenue despite a decrease in net income.

SU Group Holdings Limited secures a distribution agreement with Shine Union Limited to market and sell security products in Hong Kong, replacing a prior agreement from 2021.

Bon Natural Life Limited's fiscal year 2024 saw a revenue decrease due to changing market dynamics and a strategic focus on bioactive food ingredients.

DDC Enterprise Limited's 20-F filing highlights a 14.4% revenue increase in 2023, alongside strategic shifts towards international expansion and brand acquisitions.